Yuichiro Kadonaga

Toyonaka, 5600043, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Solid-Phase Oligosaccharide Synthesis with Highly Complexed Peptidoglycan Fragments.

Solid-Phase Oligosaccharide Synthesis with Highly Complexed Peptidoglycan Fragments.

Journal: Molecules (Basel, Switzerland)

Published: June 05, 2025

Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.

Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.

Journal: International journal of molecular sciences

Published: October 27, 2024

Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Journal: International journal of molecular sciences

Published: October 27, 2024

Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models.

Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models.

Journal: International journal of molecular sciences

Published: September 14, 2024

Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer.

Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer.

Journal: International journal of molecular sciences

Published: April 17, 2024

Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.

Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.

Journal: International journal of molecular sciences

Published: November 30, 2023

Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine.

Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine.

Journal: International journal of molecular sciences

Published: March 30, 2023

Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations.

Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations.

Journal: PET clinics

Published: March 30, 2023

Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection.

Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection.

Journal: Pharmaceutics

Published: October 13, 2022

Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound.

Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 20, 2022

Revisiting Glycosylations Using Glycosyl Fluoride by BF3·Et2O: Activation of Disarmed Glycosyl Fluorides with High Catalytic Turnover.

Revisiting Glycosylations Using Glycosyl Fluoride by BF3·Et2O: Activation of Disarmed Glycosyl Fluorides with High Catalytic Turnover.

Journal: Organic letters

Published: December 21, 2021

Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy.

Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy.

Journal: Journal of nanobiotechnology

Published: April 11, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026